Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness.

MLA

Kacała, Arkadiusz, et al. “Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness.” Cancers, vol. 16, no. 2, Jan. 2024, p. 380. EBSCOhost, https://doi.org/10.3390/cancers16020380.

APA

Kacała, A., Dorochowicz, M., Korbecki, A., Sobański, M., Puła, M., Patrzałek, D., Janczak, D., & Guziński, M. (2024). Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness. Cancers, 16(2), 380. https://doi.org/10.3390/cancers16020380

Chicago

Kacała, Arkadiusz, Mateusz Dorochowicz, Adrian Korbecki, Michał Sobański, Michał Puła, Dariusz Patrzałek, Dariusz Janczak, and Maciej Guziński. 2024. “Transarterial Bleomycin–Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness.” Cancers 16 (2): 380. doi:10.3390/cancers16020380.